Skip to main content

Advertisement

SpringerLink
Log in

Emergence of Ceftriaxone Resistant Shigella

  • Clinical Brief
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Shigellosis is endemic in many resource-poor countries due to feco-oral transmission, resulting in considerable morbidity and mortality. There is rapid emergence of multi-drug resistant (MDR) Shigella spp. resulting in poor reliability of first line antibiotics like quinolones, co-trimoxazole and ampicillin. Ceftriaxone has been used as a reserved antibiotic for treatment of MDR Shigella spp. The authors report a case of ceftriaxone resistant Shigella flexneri successfully managed with meropenem. As occurrence of ceftriaxone resistant Shigella is still rare, the objective of reporting this case is to highlight the possible failure of ceftriaxone in treating shigellosis which if not detected timely can result in mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type, Geneva: World Health Organization. WHO (2005).

  2. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2008.

  3. Mandall J, Mondal N, Mahadevan S, et al. Emergence of resistance to third-generation cephalosporin in Shigella - a case report. J Trop Pediatr. 2010;56:278–9.

    Article  Google Scholar 

  4. Gupta S, Mishra B, Muralidharan S, Srinivasa H. Ceftriaxone resistant Shigella flexneri, an emerging problem. Indian J Med Sci. 2010;64:556–9.

    Article  Google Scholar 

  5. Seidlein LV, Kim DR, Ali M, et al. A multicentre study of shigella diarrhea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med. 2006;3:e353.

    Article  Google Scholar 

  6. Srinivasa H, Baijayanti M, Raksha Y. Magnitude of drug resistant Shigellosis: a report from Bangalore. Indian J Med Microbiol. 2009;27:358–60.

    Article  PubMed  CAS  Google Scholar 

  7. Fortineau N, Naas T, Gaillot O, Nordmann P. SHV-type extendedspectrum -lactamase in a Shigella flexneri clinical isolate. J Antimicrob Chemother. 2001;47:685–8.

    Article  PubMed  CAS  Google Scholar 

  8. Emergence of Shigella flexneri 2a Resistant to Ceftriaxone and Ciprofloxacin - South Carolina, October 2010. JAMA. 2011; 305: 776.

Download references

Conflict of Interest

None.

Role of Funding Source

None.

Author information

Authors and Affiliations

  1. Department of Clinical Microbiology and Immunology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110060, India

    Neeraj Goel & Chand Wattal

  2. Department of Pediatrics, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, India

    Dinesh Kaul & V. K. Khanna

Authors
  1. Neeraj Goel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chand Wattal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dinesh Kaul
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. K. Khanna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chand Wattal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goel, N., Wattal, C., Kaul, D. et al. Emergence of Ceftriaxone Resistant Shigella. Indian J Pediatr 80, 70–71 (2013). https://doi.org/10.1007/s12098-011-0669-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-011-0669-5

Keywords

Search

Navigation